ABIGAIL LEE: Open Payments
NPI 1467941799 · BROOKHAVEN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 23 payments from 11 companies in 2025. Trend: 2023 $945 · 2024 $1,098 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $103 |
| Astellas Pharma US Inc | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Boston Scientific Corporation | 1 | $52 |
| ABBVIE INC. | 2 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Amgen Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Veozah, Ozempic, General - Pain Management, UBRELVY, TZIELD, Kerendia, Rybelsus, BREZTRI.
Industry payments across GA — which companies pay providers there.
